Symyx Technologies Inc. (SMMX) – An Important Business Resource for Modern Industries
Though the healthcare industry is known for high margins, the biotechnology sector is infamous with investors for prolonged developmental phases. Therefore, a stock from this futuristic area with more than 11% return on average equity over the last four quarters is very interesting. The stock has a net margin on Trailing Twelve Months (TTM) basis approaching nearly 25%. The company has direct impact on corporate R&D in all Life Science applications. It sells software and highly specialized equipment to link individual laboratories, to provide vast and convenient information support, and to automate laborious processes. The business therefore relates to making…